Clinical Research Contracts Template for Canada
Generate a bespoke document
What is a Clinical Research Contracts?
A clinical research contract governs the relationship between a study sponsor, clinical research organisation, and investigator site for the conduct of a clinical trial. In Canada, trials are regulated under the Food and Drugs Act and Health Canada's Clinical Trial Regulations, and must receive REB approval before commencement. The contract must address regulatory compliance, IP ownership, participant data privacy under PIPEDA, adverse event reporting timelines, and indemnification for participant injury.
Frequently Asked Questions
What is a clinical research contract in Canada?
A clinical research contract is a written agreement between a sponsor, a clinical research organisation (CRO), and an investigator site (such as a hospital or university). It covers the scope of the study, regulatory compliance obligations under Health Canada's Food and Drugs Act, financial terms, intellectual property rights, and data handling responsibilities.
Does Health Canada need to approve a clinical trial before a contract is signed?
A Clinical Trial Application (CTA) must be submitted to Health Canada and either approved or allowed to proceed by default before a clinical trial may commence. The clinical research contract is typically finalised in parallel with the CTA process, but the trial cannot begin until Health Canada authorisation is in place.
What role do Research Ethics Boards play in Canada?
Every clinical trial involving human participants in Canada must receive approval from an accredited Research Ethics Board (REB) before it begins. REBs review study protocols, informed consent documents, and participant protections. The clinical research contract must confirm that REB approval is a condition precedent to commencement of the study.
What does the clinical research contract say about intellectual property?
IP terms are heavily negotiated. Sponsors typically retain ownership of all data and inventions arising from the study. Academic institutions may seek publication rights and, in some cases, a share of commercialisation proceeds. The contract should clearly assign ownership of inventions, data, and background IP, and address publication timelines and peer-review rights.
How does PIPEDA apply to clinical research data in Canada?
PIPEDA governs the collection, use, and disclosure of identifiable participant data by private-sector organisations. Research contracts must specify how participant data is collected, stored, anonymised, and protected, and must address cross-border data transfer restrictions if the sponsor processes data outside Canada.
What are a sponsor's adverse event reporting obligations in Canada?
Under Health Canada's regulations, sponsors must report serious unexpected adverse drug reactions (SUSARs) to Health Canada within defined timeframes, typically 7 days for fatal or life-threatening events and 15 days for others. The clinical research contract must specify the investigator's obligations to report adverse events to the sponsor promptly to enable compliance.
Who bears liability for participant injury in a Canadian clinical trial?
The contract should specify indemnification obligations. Sponsors typically indemnify investigator sites and principal investigators for claims arising from the study drug or device, excluding negligence by the site. Sites indemnify the sponsor for their own negligence. The contract should require the sponsor to carry adequate clinical trial liability insurance.
Can a clinical research contract be terminated early in Canada?
Yes. Termination clauses should address sponsor-initiated termination for convenience (with reasonable notice), termination for cause by either party on material breach, and mandatory termination if Health Canada or the REB withdraws approval. The contract should specify obligations on data handover, participant follow-up, and payment of outstanding costs on termination.
About the Clinical Research Contracts
Clinical Research Contracts are comprehensive legal agreements that establish the framework for conducting human subjects research in the United States. You need these specialized contracts whenever pharmaceutical companies, medical device manufacturers, or other research sponsors collaborate with hospitals, universities, or research institutions to conduct clinical trials. These agreements ensure all parties understand their obligations while maintaining compliance with strict federal regulations governing human subjects research.
When do you need this document?
You require a Clinical Research Contract when initiating any clinical study involving human participants in the United States. This includes Phase I through Phase IV pharmaceutical trials, medical device studies, behavioral research, and investigational treatment protocols. The contract is essential when a research sponsor engages a principal investigator at an academic medical center, hospital system, or independent research facility. You also need this agreement when contract research organizations coordinate multi-site studies, when establishing international collaborations that include U.S. sites, or when conducting post-market surveillance studies required by the FDA.
Key legal considerations
Your Clinical Research Contract must address critical liability and indemnification provisions, as research involving human subjects carries significant legal risks. The agreement should clearly define each party's responsibilities for adverse event reporting, data integrity maintenance, and regulatory compliance. You need robust intellectual property clauses covering invention ownership, publication rights, and confidentiality of proprietary information. Financial terms must specify payment schedules, cost overruns, and reimbursement for screen failures or early terminations. The contract should include detailed termination provisions allowing either party to end the study while protecting subject safety and data integrity. Insurance requirements and coverage limits must be clearly specified, particularly for investigator liability and institutional coverage.
Legal requirements in the United States
Your Clinical Research Contract must comply with the Common Rule (45 CFR Part 46), which mandates Institutional Review Board approval and ongoing oversight of human subjects research. The agreement must incorporate HIPAA requirements for protected health information, including data use agreements and privacy safeguards. FDA regulations under 21 CFR Parts 50, 56, and 312 govern informed consent procedures, IRB standards, and investigational drug protocols that must be referenced in your contract. Good Clinical Practice guidelines require specific documentation standards and quality assurance measures. State laws may impose additional requirements for informed consent, medical malpractice coverage, and professional licensing that your contract must address. The agreement should include provisions for FDA inspections, audit rights, and regulatory reporting obligations that ensure continuous compliance throughout the study duration.
GOVERNING LAW
Applicable law
This Clinical Research Contracts is drafted to comply with Canada law. Key legislation includes:
Explore 208,390+ legal templates
Explore 208,390+ legal templates
Genie's Security Promise
Genie is the safest place to draft. Here's how we prioritise your privacy and security.
Your data is private:
We do not train on your data; Genie's AI improves independently
All data stored on Genie is private to your organisation
Your documents are protected:
Your documents are protected by ultra-secure 256-bit encryption
We are ISO27001 certified, so your data is secure
Organizational security:
You retain IP ownership of your documents and their information
You have full control over your data and who gets to see it